BioCentury | Jan 25, 2017
Distillery Therapeutics

Cancer

...published online Jan. 19, 2017 doi:10.1038/ncomms14073 CONTACT: Giannino Del Sal, National Laboratory of the Interuniversity Consortium for Biotechnology, Trieste, Italy email: delsal@lncib.it Hongjiang Li National Laboratory of the Interuniversity Consortium for Biotechnology Glucocorticoid...
BioCentury | Feb 5, 2009
Targets & Mechanisms

Another notch on cancer's belt

Italian researchers have identified peptidyl prolyl isomerase as a new player in the Notch signaling pathway that could be targeted to help treat cancer. 1 The findings potentially open a new avenue for cancer therapies...
Items per page:
1 - 2 of 2
BioCentury | Jan 25, 2017
Distillery Therapeutics

Cancer

...published online Jan. 19, 2017 doi:10.1038/ncomms14073 CONTACT: Giannino Del Sal, National Laboratory of the Interuniversity Consortium for Biotechnology, Trieste, Italy email: delsal@lncib.it Hongjiang Li National Laboratory of the Interuniversity Consortium for Biotechnology Glucocorticoid...
BioCentury | Feb 5, 2009
Targets & Mechanisms

Another notch on cancer's belt

Italian researchers have identified peptidyl prolyl isomerase as a new player in the Notch signaling pathway that could be targeted to help treat cancer. 1 The findings potentially open a new avenue for cancer therapies...
Items per page:
1 - 2 of 2